The development of the production technology of (177)Lutetium trichloride

被引：0

作者：

Novikov, S. G. ^{[1
]}

Berintsev, A. V. ^{[1
]}

Alekseyev, A. S. ^{[1
]}

Svetukhin, V. V. ^{[1
]}

Kuznetsov, R. A. ^{[1
]}

Zhukov, A. V. ^{[1
]}

Fomin, A. N. ^{[1
]}

Kovalnogov, V. N. ^{[1
]}

Gorodetsky, V. G. ^{[2
]}

Karbolin, P. V. ^{[2
]}

Predeina, M. A. ^{[2
]}

Ivshin, S. A. ^{[2
]}

Ilyin, K. I. ^{[2
]}

Markov, D. V. ^{[2
]}

机构：

[1] Ulyanovsk State Univ, SP Kapitsa Res Inst Technol, Ulyanovsk, Russia

[2] JSC Inst Reactor Mat, Zarechnyi, Russia

来源：

JOURNAL OF COMPUTATIONAL METHODS IN SCIENCES AND ENGINEERING | 2018年 / 18卷 / 03期

关键词：

Technology; lutetium-trichloride-177; reactor irradiation; technological equipment; automated system;

D O I：

10.3233/JCM-180822

中图分类号：

T [工业技术];

学科分类号：

08 ;

摘要：

The results of the development of a new technological process and equipment for the production of trichloride-lutetium-177 at the JSC "Institute of Reactor Materials" are presented. A new technological process is proposed for the production of a radiopharmaceutical precursor of lutetium trichloride 177LuCl3, which comprises more than thirty technological and control operations. New technological equipment has been developed to ensure the implementation of technological operations within the process. The behavior modeling of the devices being developed in high-intensity radiation fields has been carried out.

引用

页码：709 / 713

页数：5

共 50 条

[41] Lutetium-(177Lu)-oxodotreotideVarious toxicities
Reactions Weekly, 2024, 1999 (1) : 230 - 230
[42] Nanodiamonds as Lutetium-177 Carriers for Nuclear Medicine
Kazakov, A. G.
Babenya, J. S.
Ekatova, T. Y.
Vinokurov, S. E.
Khvorostinin, E. Y.
Ushakov, I. A.
Zukau, V. V.
Stasyuk, E. S.
Nesterov, E. A.
Sadkin, V. L.
Rogov, A. S.
Myasoedov, B. F.
RADIOCHEMISTRY, 2024, 66 (02) : 191 - 197
[43] Lutetium (177lu) oxodotreotideDiarrhoea: case report
Reactions Weekly, 2019, 1751 (1) : 248 - 248
[44] Lutetium Lu 177 Vipivotide Tetraxetan: First Approval
Keam, Susan J.
MOLECULAR DIAGNOSIS & THERAPY, 2022, 26 (04) : 467 - 475
[45] Lutetium-(177Lu)-oxodotreotideNephrotoxicity and thrombocytopenia
Reactions Weekly, 2024, 1998 (1) : 292 - 292
[46] Lutetium-(177Lu)-oxodotreotideMyeloid neoplasm
Reactions Weekly, 2024, 1998 (1) : 291 - 291
[47] Lutetium-177-rhPSMA10.1Thrombocytopenia and anaemia
Reactions Weekly, 2024, 2014 (1) : 374 - 374
[48] Lutetium-(177Lu)-oxodotreotideLack of efficacy
Reactions Weekly, 2024, 2003 (1) : 522 - 522
[49] Lutetium 177 dotatate induced acute myeloid leukemia
Vallathol, Dilip Harindran
Ali, Abubacker Zakir
Alapati, Neeharika
Manasa, Navya
Vasanth, Prasad
Digumarti, Raghunadharao
LEUKEMIA & LYMPHOMA, 2020, 61 (13) : 3263 - 3265
[50] Lutetium-177-PSMA-imaging-and-therapyVarious toxicities
Reactions Weekly, 2024, 1991 (1) : 135 - 135

← 1 2 3 4 5 →